TAIP Conference I Psychedelics: Science & Therapy

TAIP Foundation is organising an international scientific conference on October 8–9, 2026, at the National Library of Estonia, focusing on psychedelic-assisted therapy and its role in modern mental healthcare.

This two-day conference brings together scientists, physicians, psychologists, and policymakers from Estonia and abroad to explore the scientific foundations, clinical practice, and future directions of psychedelic-assisted therapy in Europe and Estonia.

The aim of the conference is to build a shared understanding of this rapidly evolving field by bringing together research, clinical experience, and international best practices.

What to expect?

Over two days, participants will gain a comprehensive overview of the development of psychedelic-assisted therapy — from research to clinical practice and regulatory approaches.

Topics include:

• the use of psilocybin, MDMA, and ketamine in mental health treatment;

• clinical trials and their outcomes;

• the therapeutic process and the role of psychotherapy;

• international practices and regulatory models;

• future developments in Europe.

October 8: Scientific basis and clinical studies
The first day focuses on the scientific foundations and clinical research of psychedelic-assisted therapies. It explores the mechanisms of action of different psychedelic compounds, findings from clinical studies, and the implementation of psychedelic-assisted therapies in clinical practice.

👉 Explore Day 1 programme.

October 9: From innovation to implementation
The second day focuses on how psychedelic-assisted therapies move from scientific research into clinical practice. It explores international implementation models, regulatory frameworks, and the next steps for advancing psychedelic-assisted therapies in Estonia.

👉 Explore Day 2 programme.

International speakers

The conference will feature leading experts in the field, including:

• David Nutt – one of the world’s foremost researchers in psychedelics; professor of neuropsychopharmacology (Imperial College London).

• Lowan Stewart – developer of ketamine-assisted therapy in Norway; medical director (Axonklinikken).

• Helena Aicher – clinical practitioner in psychedelic-assisted therapy in Switzerland; researcher (University of Zurich).

• Tadeusz Hawrot – founder and CEO of PAREA
  and others.

👉 Discover the speakers here.

Estonian experts and field specialists will also participate in discussions. The speaker lineup and programme are continuously updated.
Follow updates at: sataip.ee/conference.

Networking Events

In addition to the daytime programme, networking events will take place on both conference evenings, offering opportunities to continue discussions, build new connections, and meet speakers and fellow participants.

October 8 - Synapse Lounge
8:00 PM - 00:00 AM | F-Hoone, Black Hall, Telliskivi Creative City

After the first day of the conference, the evening continues in a relaxed and inspiring atmosphere. Synapse Lounge is an informal gathering where you can meet speakers, fellow participants and the organising team, continue conversations sparked during the day, and make new connections.

Enjoy a live DJ, a welcoming lounge atmosphere, complimentary light snacks, and a cash bar where drinks are available for purchase.

This event is exclusive to 2-day ticket holders

October 9 - Afterglow
4:00 PM - 7:00 PM | Skyline Hall (7th Floor), National Library of Estonia

We’ll close the conference in a relaxed and inspiring setting with one of the most beautiful panoramic views of Tallinn. Afterglow offers a chance to slow down, reflect on the past two days of the conference, continue meaningful conversations and connect with fellow participants before heading home. Enjoy great company, breathtaking city views, and the autumn sunset over Tallinn.

This event is exclusive to 2-day ticket holders.

Who is this conference for?

• Mental health professionals (psychiatrists, psychologists, psychotherapists):

• healthcare professionals and decision-makers;

• public sector representatives;

• researchers and students;

• anyone interested in understanding developments in this field from a scientific perspective.

Why does this matter?

Europe is facing a mental health crisis that requires additional treatment approaches. Mental health challenges have a significant impact on both individuals and society. According to the OECD, this impact amounts to approximately 4% of GDP — in Estonia, this equals over €1.6 billion annually.

At the same time, new approaches are being explored internationally to complement existing treatments. Psychedelic-assisted therapy is a rapidly developing field that deserves attention.

We create a space for science-based discussion, bringing together international experience and the Estonian context. Our goal is to support informed and responsible decision-making in the development of this field, expand evidence-based treatment options, and improve access to care for those who need it.

Tickets

Standard-price tickets (€190) are available until 7 September.

👥 Group discount: For groups of 3 to 5 participants, the ticket price is €169 per person (valid until 7 September).

From 8 September, the ticket price is €220.

The conference ticket includes lunch and coffee breaks. Vegetarian catering will be provided throughout the conference.

Follow updates at: sataip.ee/conference

See you at the conference!